Source: Annual Congress 2010 - Advances on breath monitoring of inflammatory airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. T. Dinh-Xuan (Paris, France). Alveolar NO and alveolar inflammation: biological links and clinical implications. Annual Congress 2010 - Advances on breath monitoring of inflammatory airway disease

Member's Comments

No comment yet.

Related content which might interest you: Inflammatory cells and airway remodelling in COPD: clinical implications Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Clinical assessment and management of pulmonary alveolar proteinosis: the importance of a reference centre Source: Annual Congress 2009 - Pulmonary alveolar proteinosis: clearing the Milky Way Year: 2009 The GPx1-PTP1B-PP2A axis: A key determinant of airway inflammation and alveolar destruction Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights Year: 2013 Alveolar proteinosis: epidemiology, possibilities of diagnosis Source: Eur Respir J 2004; 24: Suppl. 48, 671s Year: 2004 Disrupted alveolar repair in COPD: lessons from patient studies and models systems Source: International Congress 2018 – Pathophysiology of the human lung alveolus Year: 2018 Clinical and functional features in idiopathic pulmonary fibrosis (IPF) with and without haemosiderin-laden alveolar macrophages on BALF Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosis Source: ERJ Open Res, 4 (1) 00071-2017; 10.1183/23120541.00071-2017 Year: 2018 Possible ocular involvement in pulmonary alveolar proteinosis Source: Eur Respir J 2006; 28: 456 Year: 2006 Increased apoptosis of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF). Potential mechanisms and practical considerations Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Late Breaking Abstract - Alveolar macrophages preferentially take up microvesicles in the alveolar space Source: International Congress 2017 – Novel mechanisms and therapeutic targets in lung injury and repair Year: 2017 Late Breaking Abstract - Phase 2 trial evaluating the effects of dexpramipexole on blood eosinophils, lung function, and airway biomarkers in eosinophilic asthma Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs Year: 2021 Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevance Source: Eur Respir J 2010; 35: 1312-1321 Year: 2010 Pathogenetic pathways in pulmonary fibrosis: The role of bronchoalveolar lavage (BAL) cellularity in relation to epithelial injury Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Lung fibrosis in Pulmonary Alveolar Proteinosis (PAP): different stages of a syndrome or distinct diseases? Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Dual pathways of asthmatic inflammation and clinical implications Source: Annual Congress 2003 - New insights in airway inflammation Year: 2003 Alveolar macrophage proteinase/antiproteinase expression in lung function and emphysema Source: Eur Respir J 2014; 43: 82-91 Year: 2004 Lung inflammation: The role of alveolar macrophages Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 Mast cells in lung disease: clinical implications Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019